Results 261 to 270 of about 50,846 (317)

Podocyte dysfunction driven by heme in sickle-cell nephropathy. [PDF]

Sci Rep
Ben Ali C, Morel A, Morvan M, Moktefi A, Nguyen-Peyre KA, Van Wynsberghe M, Sakhi H, Bartolucci P, Audard V, Hénique C.   +9 more
europepmc   +1 more source

Selective modulation of the secretion of cathepsin L and its inhibitor by b-FGF in differentiated cultured podocytes.

, 2002
Katsuhiko Asanuma
openalex   +2 more sources

Notch signaling in diabetic kidney disease: recent progress. [PDF]

Front Endocrinol (Lausanne)
Wang ZH, Tu W, Long YN, Li PF, He KY, Wu J.   +5 more
europepmc   +1 more source

LCZ696 improves oxidative stress injury in human podocytes induced by increased glucose levels via Nrf2/HO-1 signaling pathway. [PDF]

Eur J Med Res
Zhang H, Yu M, Zhang Y, Lu D, Liu G.
europepmc   +1 more source

Correction: LCZ696 improves oxidative stress injury in human podocytes induced by increased glucose levels via Nrf2/HO-1 signaling pathway. [PDF]

Eur J Med Res
Zhang H, Yu M, Zhang Y, Lu D, Liu G.
europepmc   +1 more source

ORM1 Mediates Ln-IgG-Induced Podocyte Damage and Autophagy via the AMPK/mTOR Signaling. [PDF]

Organogenesis
Chen J, Zou L, Liu L, Wu C, Hu M.
europepmc   +1 more source

Serum Factors in Primary Podocytopathies. [PDF]

Antibodies (Basel)
Filippone EJ, Farber JL.
europepmc   +1 more source

Case Report: Fabry disease overlapping with systemic lupus erythematosus in a pediatric patient. [PDF]

Front Immunol
Liu Y, Luo J, Wu N, Luo K, Liu J, Sun L.
europepmc   +1 more source

Programmed Cell Death in Diabetic Kidney Disease: Mechanisms and Therapeutic Targeting. [PDF]

J Inflamm Res
Tang S, Sun Y, Sun W, Kang X, Zhao X, Jiang L, Gao Q, An X, Ji H, Lian F.   +9 more
europepmc   +1 more source

Podocyte RIPK3 Deletion Improves Diabetic Kidney Disease by Attenuating NF-κB p65 Driven Inflammation. [PDF]

Adv Sci (Weinh)
Li L, Li J, Li R, Zhao X, Chen Y, Cai Y, Yang Y, Wang W, Zheng S, Zhang L, Liang X.   +10 more
europepmc   +1 more source